Skip to content

Hippocampal miR-34a/SIRT1 and BDNF Responses Following Adolescent Stress: Differential Effects of Ketamine and Fluoxetine.

Feyza Dönmez, Gülin Özdamar Ünal, Kuyaş Hekimler Öztürk, Duygu Kumbul, Eltaf Doğan

Turk psikiyatri dergisi = Turkish journal of psychiatry 2026 DOI: 10.5080/u27776 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled experimental animal study Peer reviewed
Sample size 40
Population Male Wistar albino rats, 4 weeks old at start
Interventions Fluoxetine Ketamine
Dose Fluoxetine 10 mg/kg, i.p.; ketamine 10 mg/kg, i.p.
Duration 6-week chronic unpredictable mild stress; fluoxetine and ketamine administered during the last 3 weeks; behavioral assessments at weeks 3 and 6
Measures Sucrose preference test (SPT), open field test (OFT), forced swim test (FST), ELISA for BDNF protein, RT-PCR for miR-34a, SIRT1, and NLRP3 gene expression
Topics Depression Ketamine Esketamine
Keywords Early life stress Fluoxetine Mir-34a sirt1.
Key findings Adolescent chronic unpredictable mild stress induced depression-like behaviors and decreased hippocampal BDNF while increasing miR-34a. Fluoxetine reversed the miR-34a increase and raised SIRT1 and BDNF levels; ketamine improved behavior but did not significantly alter BDNF, SIRT1, or miR-34a. No significant group differences in NLRP3 expression were observed. The authors argue that fluoxetine's effects are associated with the miR-34a/SIRT1/BDNF axis, whereas ketamine may act through different, possibly extra-hippocampal mechanisms.

Abstract

Early life stress is a well-established risk factor for psychiatric disorders in adulthood; however, the underlying molecular mechanisms remain unclear. This study investigated the effects of chronic unpredictable mild stress (CUMS) starting in adolescence on anxiety- and depression-like behaviors, as well as on hippocampal miR- 34a, SIRT1, BDNF, and NLRP3 levels in rats treated with ketamine or fluoxetine. A total of 40 Wistar albino rats (4 weeks old) were divided into four groups: Control, CUMS, CUMS + fluoxetine (FLU), and CUMS + ketamine (KETA). Chronic unpredictable mild stress was applied for 6 weeks, while fluoxetine (10 mg/kg, i.p.) and ketamine (10 mg/kg, i.p.) were administered during the last 3 weeks. Behavioral assessments were performed at weeks 3 and 6 using the sucrose preference test (SPT), open field test (OFT), and forced swim test (FST). Hippocampal BDNF protein levels were measured by ELISA, and miR-34a, SIRT1, and NLRP3 gene expression levels were analyzed by RT-PCR. Both fluoxetine and ketamine improved CUMS-induced depression-like behaviors. Chronic unpredictable mild stress decreased hippocampal BDNF levels and increased miR-34a expression. Fluoxetine reversed the increase in miR-34a and elevated SIRT1 expression and BDNF levels. In contrast, although ketamine improved behavioral outcomes, it did not significantly alter hippocampal BDNF or SIRT1 levels and did not reduce miR-34a expression. No significant differences in NLRP3 expression were observed among the groups. Adolescent CUMS induces depression-like behaviors by affecting the hippocampal miR-34a/SIRT1/BDNF axis. While the antidepressant effects of fluoxetine are associated with this axis, ketamine may exert its behavioral effects through different and possibly extra-hippocampal mechanisms. miR-34a may serve as a potential biomarker for depression related to early life stress.

Comparable studies

Other preclinical and animal studies on ketamine for depression, most cited first.

Citations in the library

Explore topics

By condition and practice